Literature DB >> 11012609

Chronic granulomatous disease.

D Goldblatt1, A J Thrasher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11012609      PMCID： PMC1905749          DOI： 10.1046/j.1365-2249.2000.01314.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  133 in total

1.  Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

Authors:  H L Malech; P B Maples; N Whiting-Theobald; G F Linton; S Sekhsaria; S J Vowells; F Li; J A Miller; E DeCarlo; S M Holland; S F Leitman; C S Carter; R E Butz; E J Read; T A Fleisher; R D Schneiderman; D E Van Epps; S K Spratt; C A Maack; J A Rokovich; L K Cohen; J I Gallin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease.

Authors:  S E Caldwell; C E McCall; C L Hendricks; P A Leone; D A Bass; L C McPhail
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  A second NsiI RFLP at the CYBB locus.

Authors:  T J Mühlebach; W Robinson; R A Seger; M Mächler
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

Review 4.  Chronic granulomatous disease: mutations in cytochrome b558.

Authors:  D Roos; M De Boer; A De Klein; B G Bolscher; R S Weening
Journal:  Immunodeficiency       Date:  1993

5.  Association of a Ras-related protein with cytochrome b of human neutrophils.

Authors:  M T Quinn; C A Parkos; L Walker; S H Orkin; M C Dinauer; A J Jesaitis
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

Review 6.  Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.

Authors:  J I Gallin
Journal:  Clin Immunol Immunopathol       Date:  1991-11

7.  Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558.

Authors:  J Huang; N D Hitt; M E Kleinberg
Journal:  Biochemistry       Date:  1995-12-26       Impact factor: 3.162

8.  [Phagotest and Bursttest (Phagoburst), test kits for study of phagocyte functions].

Authors:  W Hirt; T Nebe; C Birr
Journal:  Wien Klin Wochenschr       Date:  1994       Impact factor: 1.704

9.  Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.

Authors:  P E Newburger; R A Ezekowitz
Journal:  Hematol Oncol Clin North Am       Date:  1988-06       Impact factor: 3.722

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307
View more
  29 in total

Review 1.  Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts.

Authors:  Tricia A Missall; Jennifer K Lodge; Joan E McEwen
Journal:  Eukaryot Cell       Date:  2004-08

Review 2.  Chronic granulomatous disease.

Authors:  Alexander J Towbin; Ian Chaves
Journal:  Pediatr Radiol       Date:  2010-02-05

Review 3.  Resolution of inflammation as a novel chemopreventive strategy.

Authors:  Ha-Na Lee; Hye-Kyung Na; Young-Joon Surh
Journal:  Semin Immunopathol       Date:  2013-01-31       Impact factor: 9.623

Review 4.  Very early-onset inflammatory bowel disease: gaining insight through focused discovery.

Authors:  Christopher J Moran; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

Review 5.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 6.  Chronic inflammation: a failure of resolution?

Authors:  Toby Lawrence; Derek W Gilroy
Journal:  Int J Exp Pathol       Date:  2007-04       Impact factor: 1.925

7.  Problems in identification of Francisella philomiragia associated with fatal bacteremia in a patient with chronic granulomatous disease.

Authors:  A Friis-Møller; L E Lemming; N H Valerius; B Bruun
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Identification of subpopulations of bovine mammary-gland phagocytes and evaluation of sensitivity and specificity of morphologic and functional indicators of bovine mastitis.

Authors:  A L Rivas; R Tadevosyan; F W Quimby; T Coksaygan; D H Lein
Journal:  Can J Vet Res       Date:  2002-07       Impact factor: 1.310

Review 9.  Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.

Authors:  C M Cale; L Morton; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 10.  [Classification and diagnosis of immunodeficiency syndromes].

Authors:  K Warnatz; H-H Peter
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.